TABLE 1.

Summary of included meta‐analyses and outcomes.

Author (Year)	Last research	Included studies	Type	No. of EBRT	No. of cTURBT	Outcomes
Wang_CW (2023)	April 2021	31	RCT/NRCT	2024	2171	RTR, detrusor muscle, RFS (same‐site, 3, 12, 24 months), ORT, HPT, CTT, bladder perforation, ONR, bladder irritation
Yanagisawa_T (2022)	August 2021	29	RCT/NRCT	4484		RTR, RFS (12, 24 months), ORT, CTT, bladder perforation, detrusor muscle, muscularis mucosa, CIS
Motlagh_RS (2022)	June 2021	14	RCT/NRCT	2092		RFS (3 and 12 months), detrusor muscle, SAER
Li_ZY (2022)	January 2022	7	RCT	1870	1844	RTR, ORT, HPT, CTT, Re‐TURBT, ONR, bladder perforation, Hemoglobin deficit, Detrusor muscle, Urethral stricture, RFS (3, 12, 24 and 36 months)
Di_Y (2022)	January 2022	28	RCT/NRCT	1142		RFS (12 and 24 months), HPT, CTT, bladder irritation
Zhang_D (2020)	November 2019	19	RCT/NRCT	1870	1844	RFS (12 and 24 months)
Yang_H (2020)	April 2019	9	RCT/NRCT	1020		ORT, HPT, CTT, bladder irrigation, RFS (24 months), bladder perforation, ONR, Urethral stricture, postoperative adjuvant intravesical chemotherapy
Wu_YP (2016)	September 2016	7	RCT/NRCT	438	448	ORT, HPT, CTT, RFS (24 months), ONR, bladder perforation, bladder irritation, urethral stricture, postoperative adjuvant intravesical chemotherapy
Teoh_YJ (2020)	June 2019	13	RCT	586	569	ORT, bladder irritation, CTT, HPT, ONR, bladder perforation, detrusor muscle, RFS (12, 24 and 36 months)

Abbreviations: CTT, catheterization time; CTURBT, conventional transurethral resection of bladder tumor (CTURBT); EBTR, En‐Bloc transurethral resection of bladder tumor; HPT, hospitalization time; NRCT, non‐randomized controlled trial; ONR: obturator nerve reflex; ORT: operation time; PFS, Progression‐free survival; RTR, residual tumor rate; RFS, recurrence‐free survival; SAER: serious adverse event rates; RCT, randomized controlled trial.